Learn About Symptom Relief for Patients with Heart Failure

OSUWexnerbloglogo2014 Learn About Symptom Relief for Patients with Heart Failure. The American Lung Association has a slogan “When you can’t breathe, nothing else matters”. And that is particulary true for patients with end-stage cardiac disease. But the good news is that we have treatment approaches that can help and that is where palliative medicine comes in. I’m pleased to welcomes Associate Professor of Internal Medicine and palliative medicine specialist, Dr. Todd Barrett.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW Palliative Care
Domains; and REVIEW Symptom Burden and Treatment in Heart Failure.

You’ll also learn about the following:

  • Heart conditions that benefit from palliative medicine
  • Opioid selection and strategies for use
  • Opioid side effects
  • Fluid management strategies to improve shortness of breath
  • SGLT2 inhibitors
  • Palliative care versus hospice care
  • Incorporating palliative care into usual cardiac care
  • COVID-19 related challenges in providing palliative care

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses New Therapies for Lung Cancer

OSUWexnerbloglogo2014 CME Webcast Discusses New Therapies for Lung Cancer. On this CME webcast, we’re going to update you on the medical management of lung cancer and focus on non-small cell lung cancer. Joining our moderator in the studio is medical oncologist at the James Cancer Hospital and Professor of Internal Medicine from the Ohio State University, Dr. David Carbone.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review some of the latest practice-changing findings in the management of lung cancer; and Understand the basic principles of workup and initial lung cancer management decisions.

You’ll also learn about the following:

  • Classifying non-small cell lung cancer
  • Common side effects of driver-targeted therapies
  • What the primary care physician needs to know about co-managing patients taking driver-targeted therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

 

Understanding the Management of Depression

OSUWexnerbloglogo2014 Understanding the Management of Depression. We now have more and better medications to treat depression than the anti-tuberculosis drug created in the 1950’s. We also have much better ways to screen and identify patients with depression. We’re pleased to welcome our guests today to tell us about depression in primary care. Dr. Nazhat Taj-Schaal is an Assistant Professor of Internal Medicine in the Division of General Internal Medicine and Kelli Barnes is a pharmacist and Assistant Professor in the College of Pharmacy.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW recent updated clinical guidelines that address screening for depression, monitoring treatment effects, and integration of behavioral health into primary care; and REVIEW medication treatment options, their unique characteristics and how to choose between different therapies.

You’ll also learn about the following:

  • Epidemiology of depression
  • Different antidepressants have different properties
  • Managing depressed patients in a busy primary care practice
  • Identifying the suicidal patient
  • Practical approach to antidepressant selection
  • Setting realistic expectations for antidepressant effects

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcasts Teaches on Cardiomyopathy

OSUWexnerbloglogo2014CME Webcasts Teaches on Cardiomyopathy. On this CME webcast, we are going to give you the information you need to be able to recognize cardiomyopathy in your patients and then to be able to identify the specific cause of their cardiomyopathy. Joining our moderator in the studio are two cardiologists from the Ohio State University. Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials at Ohio State. And Dr. Brent Lampert is an Assistant Professor of Internal Medicine and the Associate Program Director for the heart failure and transplant fellowship.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the common presenting signs and symptoms of cardiomyopathy; and REVIEW the diagnostic work up for cardiomyopathy.

You’ll also learn about the following:

  • Common causes of cardiomyopathy
  • Initial diagnostic steps in cardiomyopathy
  • Follow up imaging in patients with cardiomyopathy
  • Myocardial sarcoidosis
  • Physical examination of hypertrophic cardiomyopathy
  • Takotsubo cardiomyopathy
  • Diagnosing restrictive cardiomyopathies
  • Significance and work up of diastolic dysfunction
  • Chemotherapy-induced cardiomyopathy
  • Chagas Disease (Trypanosoma infection)

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Discover Device Therapies for Heart Failure on Webcast

OSUWexnerbloglogo2014 Discover Device Therapies for Heart Failure on Webcast. In the past, we could prescribe medications or do a heart transplant, but that was about it. Now we have new devices that can help our patients with heart failure. On this CME webcast, we’re going to hear about these new devices to show you how these treatments can help them live longer and better lives. Joining our moderator in the studio are cardiologists and heart failure experts from the Ohio State University. Dr. Rami Kahwash is an Associate Professor of Internal Medicine and he is the Director of the Cardiovascular Research Organization at OSU. And Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the primary prevention strategies of the prevention of sudden cardiac death in chronic systolic heart failure and the role of Cardiac Resynchronization therapy (CRT); and UNDERSTAND indications of the new defibrillation strategies (wearable ICD and subcutaneous ICD) in the prevention of sudden cardiac death.

You’ll also learn about the following:

  • Medications versus implantable cardiac defibrillators
  • Implantable cardiac monitoring devices
  • Precautions when caring for patients with a ventricular assist device
  • Complications of ventricular assist devices
  • Investigational devices
  • Current role of the intra-aortic balloon pump

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.